Cancer Survivors in Indonesia are still hampered by the cost of treatment, this is a recommendation for the government – Cancer is a non-communicable disease with a high incidence and mortality rate and continues to increase every year so it needs to be a priority and focus for all parties.

The National Health Insurance Program (JKN) has succeeded in opening access for all levels of Indonesian society, including cancer survivors, to receive treatment and care for their health conditions.

Currently, the development of cancer treatment technology continues to provide increased hope and quality of life for cancer survivors, but on the other hand the Government is experiencing limited funding to add various innovative treatments to JKN coverage.

In a study conducted by The Swedish Institute for Health Economics (IHE) in 2021, it was found that countries with higher allocations of cancer financing showed better cancer treatment success than countries with lower allocations of cancer financing.

Also Read:
Research: Vitamin E and Selenium Supplements Can Increase Prostate Cancer Risk

Therefore, Prof. dr. Hasbullah Thabrany, MPH said that the implementation of innovative health financing could be a solution for health funding.

Photo by Anna Shvets from Pexels
Photo by Anna Shvets from Pexels

This of course requires collaboration with various parties so that it can help the government to expand the coverage of treatment for the entire community.

“Currently, Indonesia’s total health spending is still below the WHO recommendation, which is 5% of GDP (GDP) or at least 15% of the total APBN, and lower than several other countries in Asia and even Southeast Asia,” he said in a discussion with the Economic Association. Indonesian Health (IEKI) some time ago.

In addition, he continued, in recent years, BPIS Health as the manager of the National Health Insurance (JKN) program has experienced a deficit in the last few years which has prompted the Government to reduce and limit some benefits in the coverage of JKN.

The government, added Prof. Hasbullah, should not only focus on reducing the cost burden by limiting the benefits of treatment services in the JKN program, but also need to immediately look for innovative ideas to increase the allocation of funding so that patients become patients.

Also Read:
Cigarette Tax and Excise Reaches 173 Trillion, Observer: Can Be Used as a Source of Cancer Health Financing

Especially for cancer survivors, in order to be able to get the most optimal cancer therapy services and provide five years longer life expectancy and a better quality of life.